Weeks after Merck & Co. scrapped building of its Covid-19 vaccines in January, one in every of its senior manufacturing officers begun phoning his deputies, telling them their work on an epidemic shot wasn't in reality over.
The twist: Merck would manufacture the vaccine from an arch rival.
0 Comments